4What the Evidence Shows: Tinnitus Outcomes

CThe headline split: improved, unchanged, worse

Across systematic reviews of recipients with preoperative tinnitus, the largest group reports the tinnitus reduced or abolished, a smaller group reports no change, and a single-digit-percent minority reports it worse. Ramakers' review of bilateral-hearing-loss recipients found tinnitus diminished in roughly a quarter to three-quarters of patients and completely resolved in about 8-45%, with worsening reported in 0-25% across studies. Complete abolition is real but should be quoted conservatively: it happens in a substantial subset, not the majority, so 'quieter and less bothersome' is the safer expectation to set.[2015][2024][2024]

TWhy the studies are hard to compare

Trials use different instruments (Tinnitus Handicap Inventory, Tinnitus Questionnaire, visual analogue loudness), so an 'improvement' in one study is not numerically the same as in another. There is no blinding: a recipient who can now hear knows it, and expectation plus the relief of restored hearing colours every self-report. Regression to the mean inflates apparent benefit because patients are often recruited when tinnitus is at its most severe, and severe symptoms tend to drift back toward baseline regardless of treatment. Most cohorts are small, single-centre, and report short follow-up, so wide confidence intervals and selection effects are the rule.[2015][2019]

TMechanisms: why electrical hearing can quiet tinnitus

Tinnitus in deafness is widely understood as maladaptive central gain and reorganisation following deafferentation; restoring patterned afferent input via the implant can partly reverse this. Both daily electrical stimulation (a masking-like and reorganising effect) and the cognitive relief of re-entering the hearing world contribute, which is one reason the effect is hard to disentangle. Effect is typically strongest with the device on and during use; some recipients notice tinnitus return when the processor is off.[2024][2024]

CCounselling: a welcome bonus, not a selling point

For bilateral candidates, tinnitus relief should be presented as a likely secondary benefit, never as the reason to implant — the primary indication remains hearing. Over-promising abolition risks disappointment and, in the small worse-off group, a sense of betrayal; the durable, decade-scale data support a steady but not guaranteed effect. Document that a minority are unchanged and a few worse, so that this was a discussed possibility rather than a surprise.[2016][2015]